Command Palette

Search for a command to run...

Clinical Trials · NCT01399645

Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes

CompletedPhase 2Liraglutide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Enrollment
35
Start date
May 2011
Locations
1 site, Canada
Primary endpoint
To determine liver fat fraction evolution induced by liraglutide and insulin
View Liraglutide compound reference